“…To date, infections with multiple distinct and related viruses, escalating dosages, and various challenge routes have been employed to ascertain the role of CD28-CD80/86 costimulation preferentially in CD28 Ϫ/Ϫ mice but also complemented by analyses of CD80 Ϫ/Ϫ and/or CD86 Ϫ/Ϫ strains as well as ligand (anti-CD80/86 and CTLA-4Ig) and receptor (anti-CD28 and anti-CTLA-4) blockade. These viruses include LCMV (1,15,25,28,36,44,45,65,69,72,73,81); vesicular stomatitis virus (VSV) (1, 15, 43-45, 58, 69); vaccinia virus (VACV) (21,23,24,45,67,70) and the related ectromelia virus (ECTV) (21); influenza A virus (5,7,8,10,14,29,32,51,53,74), herpes simplex viruses (herpes simplex virus 1 [HSV-1] and HSV-2) (10,20,75,76); murine gammaherpesvirus 68 (MHV-68) (18,22,24,42,47,54); polyomavirus (PyV) (41), murine cytomegalovirus (MCMV) (2,3,17); and adenovirus …”